1. [P3–082]: IMMUNOHISTOCHEMICAL CHARACTERISATION OF NOVEL TAU ANTIBODIES IN TRANSGENIC ANIMALS. (1st July 2017) Authors: Bottelbergs, Astrid; Van Kolen, Kristof; Wintmolders, Cindy; Mercken, Marc Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 20 Page Start: P963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P4–047]: ANTI‐TAU ANTIBODY PROFILING FOR PASSIVE IMMUNIZATION THERAPY: COMPARING SEEDS DERIVED FROM TRANSGENIC ANIMALS AND HUMAN BRAIN TISSUE. (1st July 2017) Authors: Borgers, Marianne; Dockx, Koen; Van de Weyer, Inez; Versweyveld, Sofie; De Waepenaert, Katja; Vandermeeren, Marc; Van Kolen, Kristof; Vanhoof, Greet; Ebneth, Andreas; Mercken, Marc Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 26 Page Start: P1274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment. Issue 1 (December 2015) Authors: Sjödin, Simon; Andersson, Kerstin; Mercken, Marc; Zetterberg, Henrik; Borghys, Herman; Blennow, Kaj; Portelius, Erik Journal: Alzheimer's research & therapy Issue: Volume 7:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CSF biomarker variability in the Alzheimer's Association quality control program. Issue 3 (1st May 2013) Authors: Mattsson, Niklas; Andreasson, Ulf; Persson, Staffan; Carrillo, Maria C.; Collins, Steven; Chalbot, Sonia; Cutler, Neal; Dufour‐Rainfray, Diane; Fagan, Anne M.; Heegaard, Niels H.H.; Robin Hsiung, Ging‐Yuek; Hyman, Bradley; Iqbal, Khalid; Lachno, D. Richard; Lleó, Alberto; Lewczuk, Piotr; Molinuev... Journal: Alzheimer's & dementia Issue: Volume 9:Issue 3(2013) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators. Issue 14 (15th July 2019) Authors: Bischoff, François P.; Velter, Adriana Ingrid; Minne, Garrett; Pieters, Serge; Berthelot, Didier; De Cleyn, Michel; Gijsen, Harrie J.M.; Macdonald, Gregor; Surkyn, Michel; Van Brandt, Sven; Van Roosbroeck, Yves; Zavattaro, Chiara; Mercken, Marc; Austin, Nigel; Dhuyvetter, Deborah; Borghys, Herman... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 14(2019) Page Start: 1737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma. Issue 1 (27th May 2021) Authors: Triana‐Baltzer, Gallen; Moughadam, Setareh; Slemmon, Randy; Van Kolen, Kristof; Theunis, Clara; Mercken, Marc; Kolb, Hartmuth C. Journal: Alzheimer's & dementia Issue: Volume 13:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti‐tau antibody AT8. Issue 4 (5th February 2016) Authors: Malia, Thomas J.; Teplyakov, Alexey; Ernst, Robin; Wu, Sheng‐Jiun; Lacy, Eilyn R.; Liu, Xuesong; Vandermeeren, Marc; Mercken, Marc; Luo, Jinquan; Sweet, Raymond W.; Gilliland, Gary L. Journal: Proteins Issue: Volume 84:Issue 4(2016) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ‐secretase modulators. (20th May 2019) Authors: Petit, Dieter; Hitzenberger, Manuel; Lismont, Sam; Zoltowska, Katarzyna Marta; Ryan, Natalie S; Mercken, Marc; Bischoff, François; Zacharias, Martin; Chávez‐Gutiérrez, Lucía Journal: EMBO journal Issue: Volume 38:Number 12(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total‐Aβ42/Aβ40 ratio. (29th September 2015) Authors: Slemmon, J. Randall; Shapiro, Alice; Mercken, Marc; Streffer, Johannes; Romano, Gary; Andreasen, Niels; Zetterberg, Henrik; Blennow, Kaj Journal: Journal of neurochemistry Issue: Volume 135:Number 5(2015:Dec.) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors. Issue 1 (December 2016) Authors: Van Broeck, Bianca; Timmers, Maarten; Ramael, Steven; Bogert, Jennifer; Shaw, Leslie; Mercken, Marc; Slemmon, John; Van Nueten, Luc; Engelborghs, Sebastiaan; Streffer, Johannes Journal: Alzheimer's research & therapy Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗